Key Points With the FDA approval of GLP-1 agonists in pill form, the healthcare industry is looking to build on last year's momentum
injections with a dose of 100 nmol kg 1 of the experimental compounds
Astrocytes generate ROS through multiple enzymatic pathways, including mitochondrial sources, particularly the electron transport chain, and cytosolic enzymes such as MAO-B, diamine oxidase, and NADPH oxidases
Common causes encompass metabolic disorders like fatty acid oxidation defects and organic acidemias, renal issues such as carnitine loss due to chronic renal failure, Fanconi syndrome, dialysis, or certain medications (e.g., vancomycin), dietary factors including vegetarianism, starvation, or specific diets like the ketogenic diet, and liver diseases such as cirrhosis and fatty liver